purpose phase study assess efficacy toxicity accelerated radiation therapy schedule patients affected head neck squamous cell carcinomas various primary sites adopted concomitant boost technique allows weeks shorter treatment time delivering boost treatment phase second daily dose basic field irradiation NUMBER december NUMBER patients scheduled receive total dose gy NUMBER fractions NUMBER weeks boost encompassing macroscopic disease given second daily dose weeks basic treatment severe mucositis observed NUMBER patients late occurred NUMBER patients median years range months actuarial locoregional control rate NUMBER overall survival NUMBER univariate analysis primary site predictive factor locoregional control p NUMBER neoplasms arising oral cavity did worse conclude regimen feasible head neck squamous cell carcinoma various primary sites primary site exhibit predictive value data controlled studies needed assess role primary sites oropharynx nasopharynx ii NUMBER NUMBER fifty NUMBER NUMBER effects follow NUMBER NUMBER larynx hypopharynx oro nasopharynx